Resmed (RMD) Non Operating Investment Income (2021 - 2026)
Resmed (RMD) posted Non Operating Investment Income of -$10.1 million for Q1 2026, down 3410.46% on a QoQ basis from $306000.0 in Q4 2025, and down 79.39% year-over-year from -$49.1 million in Q1 2025.
Resmed (RMD) Non Operating Investment Income (2021 - 2026) Analysis & Trends
Resmed's Non Operating Investment Income history runs 6 years deep, the most recent figure standing at -$10.1 million for Q1 2026.
- Quarterly Non Operating Investment Income fell 79.39% year-over-year to -$10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.5 million (up 20.19% YoY) and the FY2025 annual result came in at -$10.3 million, down 154.61% from the prior year.
- Non Operating Investment Income was -$10.1 million for Q1 2026 at Resmed, down from $306000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $13.9 million in Q1 2024 and bottomed at -$15.5 million in Q2 2024.
- A 5-year average of -$2.0 million and a median of -$1.7 million in 2022 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income jumped 469.91% — and 2024, when it tumbled 876.89%.
- Resmed's Non Operating Investment Income stood at $8.4 million in 2022, then slumped by 122.56% to -$1.9 million in 2023, then advanced by 23.78% to -$1.4 million in 2024, then soared by 121.26% to $306000.0 in 2025, then plunged by 3410.46% to -$10.1 million in 2026.
- Business Quant data shows RMD's Non Operating Investment Income at -$10.1 million in Q1 2026, $306000.0 in Q4 2025, and -$6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -10.13 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.13 Mn |
| Mar 31, 2026 | -10.13 Mn |
| Dec 31, 2025 | 306,000.00 |
| Dec 31, 2025 | 306,000.00 |
| Sep 30, 2025 | -6.19 Mn |
| Sep 30, 2025 | -6.19 Mn |
| Jun 30, 2025 | -2.53 Mn |
| Jun 30, 2025 | -2.53 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | -680,000.00 |
| Sep 30, 2024 | -680,000.00 |
| Jun 30, 2024 | -15.47 Mn |
| Jun 30, 2024 | -15.47 Mn |
| Mar 31, 2024 | 13.92 Mn |
| Mar 31, 2024 | 13.92 Mn |
| Dec 31, 2023 | -1.89 Mn |
| Dec 31, 2023 | -1.89 Mn |